To better understand the effect of the COVID-19 pandemic on cannabis and CBD use, the UCLA Cannabis Research Initiative has launched the Cannabis, CBD and COVID Survey.
The social and economic impacts of the COVID-19 pandemic, coupled with high rates of infection has had an unprecedented effect on mental health. A recent CDC survey found that more than 4 in 10 Americans are struggling with pandemic-related mental health issues, including increased substance use.
"It's hypothesized that recreational cannabis, medical cannabis and CBD (cannabidiol) use has changed due to COVID-19 for a number of reasons including self-medication for mental health conditions," said Ziva Cooper, PhD, interim director and research director of the Cannabis Research Initiative. "The objective of this U.S.-based anonymous survey is to understand if and why cannabis and CBD use has changed."
The survey will:
"It's good to remember that cannabis dispensaries are deemed essential in many U.S. States and that delivery services now provide a method to obtain cannabis without the risk of exposure," Cooper said. "This means in certain states cannabis is as accessible as other essentials and most likely more accessible than many prescription medications used to treat many indications that people cite as reasons for cannabis and CBD use."
Cooper said she is interested in learning:
The initial survey will include 2,000 individuals across the U.S. to incorporate different perspectives from different areas of the country. The survey is expected to be completed by the end of the month.